PREDICTIVE VALUE OF VENOUS THROMBOEMBOLISM RISK ASSESSMENT SCORING TOOLS AMONG SURGICAL PATIENTS

Journal Title: European Journal of Biomedical and Pharmaceutical Sciences - Year 2018, Vol 5, Issue 4

Abstract

Venous thromboembolism represents a spectrum of conditions that includes deep venous thrombosis (DVT) and pulmonary embolism (PE). It is affects hospitalized and non-hospitalized patients, recurs frequently, is often overlooked, and results in long-term complications including chronic thromboembolic pulmonary hypertension (CTPH) and the post-thrombotic syndrome (PTS). This prospective study aimed at assessing the total risk score of VTE among surgical patients from the departments of General Surgery, Orthopaedics, Obstetrics and Gynaecology before a major operation using three tools- Venous thromboembolism Risk Factor Assessment by Caprini et al (tool 1), Revised Geneva Score for pulmonary embolism (tool 2) and Pretest probability of Deep Venous Thrombosis by Wells (tool 3) thus comparing their predictive value of VTE. Nine hundred and twenty patients were recruited, forty died within 48hours, forty died during follow up and twenty were lost to follow up. Data from 820 patients (250 from General Surgery, 300 from Orthopaedics; and 270 from O&G) were analysed and assessed for the risk of VTE. The administration of prophylactic anticoagulant and the modality chosen by the managing team was documented. The mean age of the patients were 44.5±15.0 years with 72% of the patients being female. Tool 1 assessed the half of the patients 410(50%) to have moderate risk of developing VTE while tool 2 and tool 3 assessed 65.9% and 92.7%to have low probability of VTE respectively. 100 (12%) of the patients studied had prophylactic anticoagulant. It was observed that the use of prophylaxis was highest in the group with the highest risk for VTE irrespective of the tool used. None of the 820 patients developed clinically overt VTE, however, the causes of death of the 100 patients excluded from analysis could not be investigated to rule out VTE. It was concluded that that none of the three tools used could be convincingly declared better than the others because no patient developed symptomatic VTE during the study period and cause of death was unknown among the patients who died.

Authors and Affiliations

Olufemi-Aworinde K. J.

Keywords

Related Articles

HAEMATOLOGICAL CHANGES IN ADMINISTRATION OF AQUEOUS IPOMOEA BATATA LEAF EXTRACT TO WISTAR RATS

Several studies have reported the significance of potato leaf (Ipomoea Batata) on different physiological systems of the human body; most reports have shown it to be medicinal, pharmacological, and efficacious in the tre...

GUIDELINES FOR DENTAL PATIENTS ON ORAL ANTICOAGULANTS AND ANTIPLATELET DRUGS - A LITERATURE REVIEW

Patients reporting to the maxillofacial surgery department for minor surgical procedures suffer from problems related to cardiovascular system, cerebrovascular diseases and other systemic diseases requiring anticoagulant...

DETERMINATION OF INFERTILITY IN INFERTILE MEN IN THE DUKAGJIN REGION IN REPUBLIC OF KOSOVO

Male infertilityis the inability of a male partner to achieve a pregnancy in a fertile female partner. The purpose of this paper is to determine of infertility in infertile men in the Dukagjini Region of Republic of Koso...

PREVALENCE OF PROINSULIN LEVEL AMONG CONTROLLED AND UNCONTROLLED TYPE 2 DIABETIC SUDANESE PATIENTS

Background: Proinsulin concentrations are highly related to atherosclerosis and cardiovascular diseases in type 2 diabetes mellitus (type 2 DM). This study was carried out to assess serum level of proinsulin among type...

CRYPTOCOCCOSIS AMONG HIV PATIENTS

Background: HIV and cryptococcal meningitis co-infection is a world-wise serious condition caused by the encapsulated yeast Cryptococcus neoformans, it is a major health problem in most developing countries, particularly...

Download PDF file
  • EP ID EP635731
  • DOI -
  • Views 158
  • Downloads 0

How To Cite

Olufemi-Aworinde K. J. (2018). PREDICTIVE VALUE OF VENOUS THROMBOEMBOLISM RISK ASSESSMENT SCORING TOOLS AMONG SURGICAL PATIENTS. European Journal of Biomedical and Pharmaceutical Sciences, 5(4), 88-91. https://europub.co.uk/articles/-A-635731